Daily FNArena News - Australia

Sirtex Medical’s SIRFLOX findings have received plaudits from peers but brokers continue to regard the outlook for the treatment as highly uncertain.

Global forecasters fear a strong El Nino is upon us, which would impact on commodity input prices for various industries.

Thorn Group continues to expand its receivables and diversify its operations, revealing strong growth in FY15.

Printed circuit board designer Altium is well positioned in a high growth sector and Deutsche Bank initiates coverage.

Fisher & Paykel Healthcare delivered a strong FY15 result but brokers are wary of the decision to directly distribute its hospital product in the US.

Weekly update on recommendation, target price, and earnings forecast changes.

The latest agreement between the government and the pharmacy industry involves cuts to the PBS and a subsequent drag on pharmacy company earnings, with Sigma and API among those impacted.

Suncorp has announced new cost saving initiatives but brokers are wary of how much will translate to the bottom line.

FNArena’s weekly update on short positions in the Australian share market.

FNArena provides a weekly update of Australian listed corporate bond issues, current pricing and yield data.